Dynavax Technologies
DVAX
#4927
Rank
C$2.47 B
Marketcap
C$21.08
Share price
0.03%
Change (1 day)
9.76%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -C$51.98 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are C$0.33 Billion. In 2024 the company made an earning of C$51.25 Million, an increase over its 2023 earnings that were of C$3.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$51.98 Million-201.41%
2024 C$51.25 M1475.31%
2023 C$3.25 M-99.2%
2022 C$0.40 B238.78%
2021 C$0.12 B-257.89%
2020 -C$76.48 Million-58.58%
2019 -C$0.19 Billion-9.32%
2018 -C$0.21 Billion60.44%
2017 -C$0.13 Billion-15.8%
2016 -C$0.16 Billion4.22%
2015 -C$0.15 Billion16.54%
2014 -C$0.13 Billion37.09%
2013 -C$90.52 Million
2010 -C$64.79 Million214.85%
2009 -C$20.58 Million-37.33%
2008 -C$32.84 Million-66.07%
2007 -C$96.78 Million16.92%
2006 -C$82.78 Million170.36%
2005 -C$30.62 Million33.39%
2004 -C$22.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$16.13 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.22 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.59 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.45 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.43 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$17.81 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$12.69 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
C$28.12 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$2.41 B-5,328.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel